Literature DB >> 29730780

Toward deciphering the mechanistic role of variations in the Rep1 repeat site in the transcription regulation of SNCA gene.

A Afek1,2, L Tagliafierro2,3, O C Glenn2,3, D B Lukatsky4, R Gordan5,6,7, O Chiba-Falek8,9.   

Abstract

Short structural variants-variants other than single nucleotide polymorphisms-are hypothesized to contribute to many complex diseases, possibly by modulating gene expression. However, the molecular mechanisms by which noncoding short structural variants exert their effects on gene regulation have not been discovered. Here, we study simple sequence repeats (SSRs), a common class of short structural variants. Previously, we showed that repetitive sequences can directly influence the binding of transcription factors to their proximate recognition sites, a mechanism we termed non-consensus binding. In this study, we focus on the SSR termed Rep1, which was associated with Parkinson's disease (PD) and has been implicated in the cis-regulation of the PD-risk SNCA gene. We show that Rep1 acts via the non-consensus binding mechanism to affect the binding of transcription factors from the GATA and ELK families to their specific sites located right next to the Rep1 repeat. Next, we performed an expression analysis to further our understanding regarding the GATA and ELK family members that are potentially relevant for SNCA transcriptional regulation in health and disease. Our analysis indicates a potential role for GATA2, consistent with previous reports. Our study proposes non-consensus transcription factor binding as a potential mechanism through which noncoding repeat variants could exert their pathogenic effects by regulating gene expression.

Entities:  

Keywords:  GATA; Parkinson’s disease; SNCA; Simple sequence repeat (SSR) variants; Transcription factors

Mesh:

Substances:

Year:  2018        PMID: 29730780      PMCID: PMC6054541          DOI: 10.1007/s10048-018-0546-8

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  51 in total

1.  Meta-analysis of alpha synuclein/ NACP polymorphism in Parkinson's disease in Japan.

Authors:  I Mizuta; M Nishimura; E Mizuta; S Yamasaki; M Ohta; S Kuno
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

2.  Genetic association between alpha-synuclein and idiopathic Parkinson's disease.

Authors:  Denise M Kay; Stewart A Factor; Ali Samii; Donald S Higgins; Alida Griffith; John W Roberts; Berta C Leis; John G Nutt; Jennifer S Montimurro; Robert G Keefe; April J Atkins; Dora Yearout; Cyrus P Zabetian; Haydeh Payami
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

3.  Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system.

Authors:  O Chiba-Falek; R L Nussbaum
Journal:  Hum Mol Genet       Date:  2001-12-15       Impact factor: 6.150

4.  Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.

Authors:  Demetrius M Maraganore; Mariza de Andrade; Alexis Elbaz; Matthew J Farrer; John P Ioannidis; Rejko Krüger; Walter A Rocca; Nicole K Schneider; Timothy G Lesnick; Sarah J Lincoln; Mary M Hulihan; Jan O Aasly; Tetsuo Ashizawa; Marie-Christine Chartier-Harlin; Harvey Checkoway; Carlo Ferrarese; Georgios Hadjigeorgiou; Nobutaka Hattori; Hideshi Kawakami; Jean-Charles Lambert; Timothy Lynch; George D Mellick; Spiridon Papapetropoulos; Abbas Parsian; Aldo Quattrone; Olaf Riess; Eng-King Tan; Christine Van Broeckhoven
Journal:  JAMA       Date:  2006-08-09       Impact factor: 56.272

5.  Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease.

Authors:  E Rockenstein; L A Hansen; M Mallory; J Q Trojanowski; D Galasko; E Masliah
Journal:  Brain Res       Date:  2001-09-28       Impact factor: 3.252

6.  The genetic contributions of SNCA and LRRK2 genes to Lewy Body pathology in Alzheimer's disease.

Authors:  Colton Linnertz; Michael W Lutz; John F Ervin; Jawara Allen; Natalie R Miller; Kathleen A Welsh-Bohmer; Allen D Roses; Ornit Chiba-Falek
Journal:  Hum Mol Genet       Date:  2014-04-28       Impact factor: 6.150

7.  Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication.

Authors:  D W Miller; S M Hague; J Clarimon; M Baptista; K Gwinn-Hardy; M R Cookson; A B Singleton
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

8.  Genomic regions flanking E-box binding sites influence DNA binding specificity of bHLH transcription factors through DNA shape.

Authors:  Raluca Gordân; Ning Shen; Iris Dror; Tianyin Zhou; John Horton; Remo Rohs; Martha L Bulyk
Journal:  Cell Rep       Date:  2013-04-04       Impact factor: 9.423

9.  Stability selection for regression-based models of transcription factor-DNA binding specificity.

Authors:  Fantine Mordelet; John Horton; Alexander J Hartemink; Barbara E Engelhardt; Raluca Gordân
Journal:  Bioinformatics       Date:  2013-07-01       Impact factor: 6.937

10.  Nonconsensus Protein Binding to Repetitive DNA Sequence Elements Significantly Affects Eukaryotic Genomes.

Authors:  Ariel Afek; Hila Cohen; Shiran Barber-Zucker; Raluca Gordân; David B Lukatsky
Journal:  PLoS Comput Biol       Date:  2015-08-18       Impact factor: 4.475

View more
  2 in total

Review 1.  The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models.

Authors:  Gabriella MacDougall; Logan Y Brown; Boris Kantor; Ornit Chiba-Falek
Journal:  Mol Ther       Date:  2021-01-09       Impact factor: 11.454

2.  Common genetic variants associated with Parkinson's disease display widespread signature of epigenetic plasticity.

Authors:  Amit Sharma; Naoki Osato; Hongde Liu; Shailendra Asthana; Tikam Chand Dakal; Giovanna Ambrosini; Philipp Bucher; Ina Schmitt; Ullrich Wüllner
Journal:  Sci Rep       Date:  2019-12-05       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.